dapsone has been researched along with drospirenone and ethinyl estradiol combination in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenfield, NP; Maibach, H | 1 |
| Keck, L; Shariff, A; Zlotoff, B | 1 |
2 other study(ies) available for dapsone and drospirenone and ethinyl estradiol combination
| Article | Year |
|---|---|
Pharmacogenomic biomarkers in dermatologic drugs.
Topics: Androstenes; Aryl Hydrocarbon Hydroxylases; Biomarkers; Chloroquine; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Dapsone; Dermatologic Agents; Dihydropyrimidine Dehydrogenase Deficiency; Ethinyl Estradiol; Fluorouracil; Glucosephosphate Dehydrogenase Deficiency; Humans; Naphthalenes; Primaquine; Quinuclidines; Terbinafine; Thiophenes | 2013 |
Acne vulgaris in the context of complex medical co-morbities: the management of severe acne vulgaris in a female with retinitis pigmentosa - utilizing pulse dye laser in conjunction with medical therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Androstenes; Anti-Infective Agents, Local; Combined Modality Therapy; Contraindications; Dapsone; Dicarboxylic Acids; Ethinyl Estradiol; Female; Humans; Lasers, Dye; Metronidazole; Mineralocorticoid Receptor Antagonists; Photosensitizing Agents; Retinal Detachment; Retinitis Pigmentosa; Rosacea; Sulfacetamide; Telangiectasis | 2014 |